Regulatory T cells (Treg) have emerged as a major mechanism in the maintenance of immunologic self-tolerance. Treg cells, which can emerge directly from the thymus (so called natural Treg cells) or be induced in the periphery (induced Treg cells) are usually CD4+CD25+ and function by inhibiting effector T cells. Elucidation of the mechanisms of Treg generation would be greatly facilitated by the identification of specific markers for Treg cells and molecules that mediate their function. We have been studying a self-tolerance system in which TCR transgenic CD4 T cells adoptively transferred into transgenic animals expressing the target antigen in multiple epithelial tissues become anergic and simultaneously develop into Treg cells capable of suppressing autoimmunity. Gene expression profiling of in vivo anergic/Treg cells compared with effector/memory T cells identified the LAG-3 gene as highly upregulated on anergic/Treg cells relative to effector/memory T cells. LAG-3hi Treg cells mediated suppression of T cell proliferative responses in an in vitro suppression system and anti-LAG-3 antibodies inhibited this suppression. These results identify LAG-3 as the first known specific cell surface marker for Treg cells that is potentially directly involved in mediating Treg function. This proposal seeks to further elucidate the mechanisms of suppression by LAG-3hi Treg cells and the specific role of the LAG-3 molecule in their activity. Specifically, we propose to: 1) Study the capacity and mechanisms of suppression mediated by Treg cells defined by expression of LAG-3 and CD25. 2) Elucidate the direct role of LAG-3 in modulating the activity of Treg cells and 3) Analyze the effect of blockade or elimination of LAG-3+ Treg cells in enhancing the activity of immunotherapies for established cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI058156-01A1
Application #
6824107
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Nabavi, Nasrin N
Project Start
2004-07-01
Project End
2009-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
1
Fiscal Year
2004
Total Cost
$361,537
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Pan, Fan; Yu, Hong; Dang, Eric V et al. (2009) Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 325:1142-6
Workman, Creg J; Szymczak-Workman, Andrea L; Collison, Lauren W et al. (2009) The development and function of regulatory T cells. Cell Mol Life Sci 66:2603-22
Szymczak-Workman, Andrea L; Workman, Creg J; Vignali, Dario A A (2009) Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. J Immunol 182:5188-92
Workman, Creg J; Wang, Yao; El Kasmi, Karim C et al. (2009) LAG-3 regulates plasmacytoid dendritic cell homeostasis. J Immunol 182:1885-91
Vignali, Dario A A; Collison, Lauren W; Workman, Creg J (2008) How regulatory T cells work. Nat Rev Immunol 8:523-32